Literature DB >> 25737623

Spontaneous Late Onset OHSS in Singleton Pregnancy in 2nd Trimester: A Rare Case.

Hampanagouda N Patil1, Rajib Roy1, Raja Pal1, Joydeb Roychowdhury2.   

Abstract

Entities:  

Year:  2014        PMID： 25737623      PMCID： PMC4342382          DOI： 10.1007/s13224-014-0600-x

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  6 in total

1.  Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor.

Authors:  Guillaume Smits; Olufemi Olatunbosun; Anne Delbaere; Roger Pierson; Gilbert Vassart; Sabine Costagliola
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

2.  Thrombosis associated with ovarian hyperstimulation syndrome in a carrier of the factor V Leiden mutation.

Authors:  S Hollemaert; J C Wautrecht; P Capel; M J Abramowicz; Y Englert; A Delbaere
Journal:  Thromb Haemost       Date:  1996-08       Impact factor: 5.249

3.  Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.

Authors:  A De Leener; L Montanelli; J Van Durme; Heedong Chae; G Smits; G Vassart; S Costagliola
Journal:  J Clin Endocrinol Metab       Date:  2005-11-08       Impact factor: 5.958

Review 4.  Spontaneous ovarian hyperstimulation syndrome in four consecutive pregnancies.

Authors:  O A Olatunbosun; B Gilliland; L A Brydon; D R Chizen; R A Pierson
Journal:  Clin Exp Obstet Gynecol       Date:  1996       Impact factor: 0.146

5.  Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management.

Authors:  Michael M Alper; Laura P Smith; Eric Scott Sills
Journal:  J Exp Clin Assist Reprod       Date:  2009-06-10

6.  Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management.

Authors:  A Delbaere; P J Bergmann; C Gervy-Decoster; M Staroukine; Y Englert
Journal:  Fertil Steril       Date:  1994-10       Impact factor: 7.329
  6 in total
  1 in total

1.  Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.

Authors:  C V Bishop; D M Lee; O D Slayden; X Li
Journal:  J Ovarian Res       Date:  2017-07-06       Impact factor: 4.234
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.